药物诱导的非传染性心肌炎:FAERS数据库的不成比例性分析
1Department of Cardiology, Affiliated Changshu Hospital of Nantong University, Changshu, China.
Expert opinion on drug safety
|October 29, 2024
概括
这项研究确定了几种药物,包括芬美特拉辛酸盐和trimethoprim+sulfamethoxazole,具有引起非传染性心肌炎的显著风险. 其中8种药物在标签上缺乏先前的肌心炎警告.
科学领域:
- 药物监督 药物监督 药物监督
- 心血管研究研究心血管研究
- 药品安全 药品安全
背景情况:
- 非传染性心肌炎是一种严重的药物不良反应.
- 识别有风险的药物对于患者安全至关重要.
研究的目的:
- 识别和评估与非传染性心肌炎风险相关的药物.
- 使用美国食品和药物管理局不良事件报告系统 (FAERS) 数据库进行全面分析.
主要方法:
- 从FAERS (2004-2024) 中提取非传染性心肌炎数据.
- 采用了信号量化技术,如报告几率比率 (ROR) 和比例报告比率.
- 标准化和分析提取的不良事件报告.
主要成果:
- 确定了10,763份针对非传染性心肌炎的不良事件报告.
- 根据ROR排名,最受欢迎的药物包括芬迪米特拉辛酸盐 (104.64) 和三甲胺+硫甲醇 (67.65).
- 在具有强烈ROR信号的前30种药物中,有8种药物在标签上缺乏心肌炎风险信息.
结论:
- 费尔斯分析显示,这些药物具有显著的,未标记的肌心炎风险信号.
- 临床实践需要密切监测与这些药物相关的潜在心肌炎.
更多相关视频
10:01Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
Published on: March 12, 2018
10.8K
14:03High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
Published on: March 24, 2023
1.8K
相关概念视频
Myocarditis II: Clinical features and Diagnostic Tests
2
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
2
Myocarditis I: Introduction
2
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2
Myocarditis III: Medical Management
2
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2
Myocarditis IV: Nursing Management
2
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
2
